The Houston company entered the capital markets to further fund trials for its immunotherapy drug candidates.
Houston pharma co. raising $139.6M through public offering, private placement
The Houston company entered the capital markets to further fund trials for its immunotherapy drug candidates.
About Our Site:
The primary purpose of the site is to provide Real Estate & Mortgage information as it relates to today’s business environment. It can also be used to answer related question you might have about buying, selling, or financing real estate.